Literature DB >> 22151845

Spinal cord stimulation: cost-benefit study.

Keith Budd1.   

Abstract

Entities:  

Year:  2002        PMID： 22151845     DOI： 10.1046/j.1525-1403.2002.02012.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN： 1094-7159


× No keyword cloud information.
  5 in total

1.  Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations.

Authors:  Nathaniel Katz; Robert H Dworkin; Richard North; Simon Thomson; Sam Eldabe; Salim M Hayek; Brian H Kopell; John Markman; Ali Rezai; Rod S Taylor; Dennis C Turk; Eric Buchser; Howard Fields; Gregory Fiore; McKenzie Ferguson; Jennifer Gewandter; Chris Hilker; Roshini Jain; Angela Leitner; John Loeser; Ewan McNicol; Turo Nurmikko; Jane Shipley; Rahul Singh; Andrea Trescot; Robert van Dongen; Lalit Venkatesan
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

2.  Dorsal column stimulator applications.

Authors:  Claudio Yampolsky; Santiago Hem; Damián Bendersky
Journal:  Surg Neurol Int       Date:  2012-10-31

3.  Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study.

Authors:  Furio Zucco; Roberta Ciampichini; Angelo Lavano; Amedeo Costantini; Marisa De Rose; Paolo Poli; Gianpaolo Fortini; Laura Demartini; Enrico De Simone; Valentino Menardo; Piero Cisotto; Mario Meglio; Luciana Scalone; Lorenzo G Mantovani
Journal:  Neuromodulation       Date:  2015-04-16

4.  Trial Versus No Trial of Spinal Cord Stimulation for Chronic Neuropathic Pain: Cost Analysis in United Kingdom National Health Service.

Authors:  Rui V Duarte; Simon Thomson
Journal:  Neuromodulation       Date:  2018-12-10

5.  Long-Term Effects of Dexmedetomidine versus Propofol During the Implantation of a Neurostimulator-A Post-Trial Follow-Up Analysis.

Authors:  Feline F J A Ter Bruggen; W Ken Redekop; Dirk L Stronks; Frank J P M Huygen
Journal:  J Pain Res       Date:  2021-11-30       Impact factor: 3.133
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.